Skip to main content
Download PDF

Number of contiguous vertebral cross-links in the spine indicates bone formation: a cross-sectional study

BMC Musculoskeletal Disorders volume 24, Article number: 736 (2023) Cite this article

Abstract

Background

As an indicator to evaluate the risk of fracture in diffuse idiopathic skeletal hyperostosis, the maximum number of vertebral bodies’ bone cross-linked with contiguous adjacent vertebrae (max VB) was developed. This study retrospectively investigates the relationship between max VB, bone mineral density (BMD), and bone metabolic markers (BMM).

Methods

In this cross-sectional study (from April 2010 to January 2022), males (n = 114) with various max VB from the thoracic vertebra to the sacrum, measured using computed tomography scans, were selected to assess femur BMD and BMM. The association of max VB with the total type I procollagen N-terminal propeptide (P1NP), tartrate-resistant acid phosphatase 5b (TRACP-5b), and bone turnover ratio (BTR = TRACP-5b/P1NP) as well as its relationship with femur BMD with P1NP and TRACP-5b, were investigated. Furthermore, the relationship between P1NP and TRACP-5b was investigated.

Results

P1NP increased in proportion to max VB and TRACP-5b increased in proportion to P1NP. Moreover, BTR was inversely proportional to max VB. Finally, femur BMD was inversely proportional to P1NP and TRACP-5b.

Conclusion

As max VB increased with P1NP—a potential osteogenesis indicator—and BTR was inversely proportional to max VB with compensatory TRACP-5b increase, max VB can be considered as a possible predictor of bone fusion.

Peer Review reports

Introduction

In diffuse idiopathic skeletal hyperostosis (DISH), a continuous and measurable osteogenesis process involves development from incomplete and pointy bone bridges to more flowing and complete bridges [1]. The formation of bone cross-links is caused by ectopic ossification in which the anterolateral ligament component of the vertebral bodies becomes an osteophyte [2]. Diseases with high propensity for ossification, such as ossification of posterior longitudinal ligament, are reported to have high bone density, but total type I procollagen N-terminal propeptide (P1NP) and tartrate-resistant acid phosphatase 5b (TRACP-5b) are reported to be lower than controls and have low metabolic turnover [3,4,5,6]. Alternatively, there are reports of bone mineral density (BMD) and bone metabolism markers (BMM) related to DISH, but no common view has been reached. Some previous reports have shown that BMD is unchanged or higher in patients with DISH than in controls, i.e., people without DISH [7,8,9,10,11,12]. With respect to bone BMM, some studies have reported higher intact parathyroid hormone levels but lower P1NP and serum sclerostin levels, while others have reported lower dickkof-1 levels, which suppress sclerostin; however, the results in none of these reports were conclusive [3, 13, 14]. The reason for such disparate results is that although DISH, which is based on whether a patient presents with or without spinal disease with a bone bridge that fits Resnick’s definition [15], involves several different populations that were analyzed together [16]. To elucidate the mechanism of DISH, we devised the maximum number of vertebral bodies involved in bone cross-linked with contiguous adjacent vertebrae without any interruption (max VB) [17]. Using the max VB index, the degree of bone cross-linking can be evaluated in 18 steps. This study aimed to investigate the impact of max VB on BMD and BMM.

Materials and methods

Study design

This retrospective cross-sectional study was conducted in Japan.

Study participants

Between April 2010 and January 2022, a total of 20,357 patients visited the Department of Orthopedic Surgery, Shizuoka City Shimizu Hospital (Shizuoka, Japan). Of these, 2176 were tested for BMD by dual-energy X-ray absorptiometry (GE Medical Systems Lunar, Chicago, IL, US). Overall, BMM was evaluated in 312 male patients. Only male patients were selected to eliminate the effects of postmenopausal osteoporosis because DISH occurs more frequently in men. Computed tomography (CT) scans (Discovery CT 750HD, GE Healthcare) of the thoracic to lumbar vertebrae and pelvis were obtained from 179 patients. By examining medical records, examination interviews, and phone interviews, we identified 132 patients without an exclusion criterion, i.e., history of hyperparathyroidism and rheumatism, steroid use, and osteoporosis drug treatment. Of 132 cases, we excluded 14 patients with sacroiliac (SI) joint ankylosis, leaving 118 patients without ankylosis. Of these 118 patients, 114 (mean age, 77 ± 9.1 years; range, 50–98 years) were selected from among male patients only, excluding 4 who had fractures within 1 year of the BMM collection.

Study variables

For the 114 patients, CT scans were obtained from the thoracic vertebra to the pelvis. CT is mainly taken for close examination of lumbar back pain and for determining surgical procedures for degenerative diseases of the spine. In addition, max VB was evaluated from the thoracic vertebra to the sacrum in consultation with three orthopedic surgeons. As per Resnick’s definition, the DISH group included patients with four or more consecutive vertebral cross-links and the non-DISH group included those with fewer than four consecutive vertebral cross-links [15]. Besides, age and bone mass index (BMI) were obtained from the medical questionnaire filled out at the time of the initial visit. The following items were selected based on the blood data collected: total serum calcium concentration, serum phosphorus concentration, TRACP-5b, P1NP, estimated glomerular filtration rate (eGFR), hemoglobin A1c (HbA1c), and femur BMD was estimated by the total. The bone turnover ratio (BTR) is defined in previous papers as TRACP-5b divided by P1NP [18].

Contents for investigation

First of all, we investigated the timing of CT, bone mineral density, and bone metabolism markers to investigate the interval between each. Next, the mean and standard deviation were compared with the following items: age, BMI, total serum calcium concentration, serum phosphorus concentration, TRACP-5b, P1NP, eGFR, HbA1c, femur BMD, and BTR between the DISH (n = 69) and non-DISH (n = 45) groups without adjustment. Furthermore, the outcomes influenced by max VB (n = 114) were investigated. Notably, the outcomes examined were P1NP, TRACP-5b, and BTR, and the confounding factors were age, eGFR, and HbA1c. Furthermore, we examined whether exposure to P1NP and TRACP-5b influenced femur BMD, with age, eGFR, HbA1c, and BMI as the confounding factors. Finally, the influence of P1NP on TRACP-5b was examined with age, eGFR, and HbA1c as confounders.

Statistical analysis

In this study, statistical analyses were performed using SPSS ver. 26 (IBM Corp., Armonk, NY) and statistical software R-4.0.3 (Index of /src/base/R-4 [r-project.org]). Missing data are 1; eGFR, 4; HbA1c. In addition, comparisons between the DISH and non-DISH groups were conducted for each item using the Mann–Whitney U test. Moreover, the outcomes significantly affected by exposure were tested using multiple linear regression. Notably, P < 0.05 was considered statistically significant in all analyses.

Results

The mean and standard deviation of the timing of CT and BMD were 57 ± 82 days (min 0 and max 364), CT and BMM were 49 ± 79 days (min 0 and max 338), and BMD and BMM were 23 ± 49 days (min 0 and max 287). Overall, the subjects’ mean age was 77 ± 9 years, P1NP 53 ± 28 ng/ml, TRACP-5b 433 ± 177 mU/dl, BTR 9 ± 3.5, eGFR 60 ± 18 ml/min/1.73 m2, HbA1c 6 ± 0.6%, max VB 5.9 ± 4.7, femur BMD 0.9 ± 0.2 g/cm2, and BMI 19.5 ± 3.1 kg/m2. The number of max VB was as follows: 0 (n = 19), 2 (n = 10), 3 (n = 16), 4 (n = 14), 5 (n = 3), 6 (n = 8), 7 (n = 6), 8 (n = 6), 9 (n = 5), 10 (n = 2), 11 (n = 4), 12 (n = 8), 13 (n = 5), 14 (n = 4), 15 (n = 2), and 17 (n = 2). The number of cases per max VB was evenly divided. Age, eGFR, max VB, P1NP, femur BMD and BTR remarkably differed between the DISH and non-DISH groups in an unadjusted comparison (Table 1).

Table 1 Comparison of each item in DISH and non-DISH
Full size table

The results of this analysis suggested that max VB may have influenced the values of P1NP and femur BMD. Therefore, we first investigated the relationship between max VB and P1NP with age, eGFR, and HbA1c as confounding factors. We found that only P1NP increased in proportion to max VB (Correlation coefficient = 0.05, P = 0.003; Fig. 1; Table 2).

Fig. 1
figure 1

Scatterplots of max VB versus P1NP. P1NP increased in proportion to max VB. max VB, the maximum number of vertebral bodies’ bone cross-linked with contiguous adjacent vertebrae; P1NP, total type I procollagen N-terminal propeptide

Full size image
Table 2 Relation between max VB and P1NP
Full size table

Besides, no significant correlation was obtained between max VB and TRACP-5b, whereas TRACP-5b increased in proportion to P1NP (Correlation coefficient = 0.1, P < 0.001; Fig. 2). BTR was inversely proportional to max VB (Correlation coefficient = − 0.48, P < 0.001; Fig. 3). Moreover, femur BMD was inversely proportional to P1NP and TRACP-5b (P1NP: Correlation coefficient = − 0.14, P = 0.018; TRACP-5b: Correlation coefficient = − 0.03, P = 0.002; Table 3).

Fig. 2
figure 2

Scatterplots of P1NP versus TRACP-5b. TRACP-5b increased in proportion to P1NP. P1NP positively correlates with TRACP-5b. P1NP, total type I procollagen N-terminal propeptide; TRACP-5b, tartrate-resistant acid phosphatase 5b

Full size image
Fig. 3
figure 3

Scatterplots of max VB versus BTR. BTR (TRACP-5b/P1NP) was inversely proportional to max VB. BTR, bone turnover ratio; max VB, the maximum number of vertebral bodies’ bone cross-linked with contiguous adjacent vertebrae; P1NP, total type I procollagen N-terminal propeptide; TRACP-5b, tartrate-resistant acid phosphatase 5b

Full size image
Table 3 Relation with femur BMD and bone metabolic marker
Full size table

Discussion

Factors influencing maxVB, BMM and BMD and the validity of this study

The incidence of DISH increases with age and the number of bone cross-links [1]. Although BMM, BMD, and CT from the thoracic to the lumbar spine were not necessarily taken at the same time, the average interval between inspection dates was 1–2 months, and all inspections were performed within a year. The number of bone bridges reported to develop over the mean course of the five-year period suggests that a gap of approximately one year is not so significant [1]. In addition, studies have reported that age, renal function, postmenopausal osteoporosis, history of hyperparathyroidism, rheumatism, and history of steroid and osteoporosis medication are factors affecting P1NP and TRACP-5b [19, 20]. Thus, the eligible patients were eliminated according to the patient’s medical records or subsequent telephonic interviews. Since we are dealing only with male patients and do not need to consider postmenopausal osteoporosis, a rapid decline in bone mineral density is unlikely to occur within a year or so. Furthermore, since no patients were treated for osteoporosis, the effect of bone metabolism markers was considered small. Finally, in a previous study, BMM did not increase until the first week following a fracture but remained elevated up to 1 year following the fracture [21, 22]. Hence, patients with fractures occurring within one year were also excluded from this study, suggesting that we eliminated as many factors as possible that could affect BMM.

Differences in BMM between DISH and ankylosing spondylitis (AS)

AS and DISH involve bone cross-linking between the vertebrae, but show completely different levels of BMD and BMM. Among BMM, bone resorption markers, such as serum C-telopeptides, which belong to type I collagen (CTX), are high in AS. Of note, higher CTX signifies lower bone density values. Both AS and DISH are similar in terms of the formation of bone bridges in the spine when bone resorption markers increase, but they differ in bone density and P1NP [23,24,25]. The elevated bone resorption markers in both diseases are different, and the augmented bone resorption in AS induces the decreased bone density, whereas bone resorption in DISH increases at the expense of accelerated bone formation. First, it is essential to distinguish AS as a prerequisite for assessing bone healing in DISH; for this, the modified New York criteria evaluated by clinical and imaging items and human leukocyte antigen B27 (HLA-B27) have been used previously [26, 27]. In this study, all tests were conducted within insurance, but HLA-B27 was not tested. Nevertheless, as the incidence of DISH is very high compared with AS, which is remarkably low (0.48/100,000), in the Japanese population, and because patients without SI joint fusion were examined in this study, the population is considered AS-free [28]. The results of this study further showed that bone density was higher in the DISH group and that only P1NP increased in proportion to max VB, with TRACP-5b showing a compensatory rise. These increases were also considered to represent DISH as they were different from the trends of BMD and BMM in AS.

Effect of max VB on P1NP

To the best of our knowledge, no paper has yet examined the effect of the number of bone cross-links on BMM. Moreover, as mentioned above, studies about BMM comparing DISH and non-DISH have not eliminated confounding factors [3, 13, 14]. P1NP, which is produced from the early stage of osteoblast differentiation, acutely reflects early bone formation; high P1NP indicates high osteogenic potential, which may be due to ectopic ossification and bone bridging after migration of osteoblast progenitor cells [29]. First, age must be adjusted because it affects both the number of bone cross-links and P1NP. As age increases, the number of bone cross-links increases, whereas P1NP decreases [1, 30]. Given these findings, we would expect P1NP to decrease with increasing max VB. Unexpectedly, P1NP was positively correlated with max VB after adjustment for other confounders. Cases exist where BMM cannot be accurately determined. In cases of spinal fractures, metastatic spinal tumors, diseases involving paralysis of the lower extremities, or bladder rectal disorders requiring urgent surgery, which must be performed without waiting for the BMM results. Moreover, BMM are difficult to determine in certain cases because they fluctuate with age, gender, fractures, autoimmune diseases, and administration of osteoporosis medications [19,20,21]. Therefore, max VB can be considered an indicator of bone formation and it is particularly useful as an indicator of bone formation when bone metabolic markers are not available or helpful.

Effect of BMM on BMD

In the present study, BMD showed a negative correlation with both bone formation and resorption markers, suggesting that high BMD and bone formation markers are incompatible. An interesting paper examined the correlation between P1NP levels and hip bone density in teriparatide-treated patients, reporting that approximately 60% of patients presented with less hip BMD, which was independent of the changes in P1NP levels [31]. This fact may support the result that when both bone formation and resorption markers as well as bone metabolic turnover are low, bone density is high. Conversely, when BMM are elevated, bone metabolic turnover is increased and bone density is low. Subsequently, we considered max VB and BMD. Regarding bone density in DISH, there have been reports of higher or unchanged bone density compared with controls [7,8,9,10,11,12]; however, bone density is higher for max VB from 4 to 8 and unchanged for max VB from 9 to 18 compared with the non-DISH group. Therefore, bone density results in cases of DISH will vary depending on the max VB [16]. This is because when max VB is between 4 and 8, bone formation and compensatory bone resorption are moderate, resulting in high BMD. Conversely, when max VB is between 9 and 18, bone formation and compensatory bone resorption are accelerated, resulting in lower BMD due to increased bone metabolic turnover.

Can max VB be a predictive indicator of bone healing?

High bone density is reported to be favorable for bone healing [32, 33]. In contrast, inhibitory factors of bone healing are low bone density, underlying factors like steroid use, and smoking history [34, 35]. Aging is a cause of osteoporosis but not necessarily a cause of bone fusion failure in spinal fusion surgery [36, 37]. Reports regarding the effects of drugs on bone fusion have stated that the weekly administration of teriparatide promoted bone union within 6 months following posterior lumbar interbody fusion [38], and there was significantly delayed union after 6 months in long-term bisphosphonate users [39]. While these factors have been reported to influence bone healing, it is not common to predict bone healing by the values of bone metabolic markers. Inoue et al. used BTR (TRACP-5b/P1NP) as an index of bone remodeling and a factor that can predict bone healing in posterior lumbar interbody fusion [18]. Notably, this index was devised because low P1NP and high TRACP-5b levels are risk factors for poor bone remodeling. Although the mechanism of bone healing in posterior lumbar interbody fusion and posterolateral fusion remains unclear, the rate of bone healing is fast-tracked in osteoinductive cages and demineralized bone fibers, which could be considered as ectopic ossification [40,41,42]. The results of this study, in which BTR was inversely proportional to maxVB, suggested that the increase in maxVB, which may have promoted ectopic ossification, enhanced bone healing.

Limitations

This study has some limitations that are worth acknowledging. First, this was a retrospective study, with a small sample size. Second, this study was analyzed using P1NP, which reacts at the early stage of bone formation, rather than osteocalcin or bone alkaline phosphatase, which is a marker of the final stage of bone formation, because the study was conducted within insurance. Finally, that bone cross-link formation in DISH is not only affected by factors owing to bone metabolism, but also by degeneration. In the future, it will be necessary to investigate bone healing after surgery for chronic spinal diseases and fractures with the degree of bone cross-linking in a prospective study.

Conclusions

This study demonstrates that max VB increased in proportion to P1NP, which was considered an indicator of bone formation. Furthermore, there was a compensatory rise in the levels of bone resorption and bone rotation increased, whereas BTR was inversely proportional to max VB, suggesting that it could be a predictor of bone healing. Hence, measuring max VB before the spinal fusion surgery is beneficial to easily confirm the possibility of bone fusion.

Data Availability

The dataset supporting the conclusions of this article is included within the article.

Abbreviations

AS:

Ankylosing spondylitis

BMD:

Bone mineral density

BMI:

Bone mass index

BMM:

Bone metabolic markers

BTR:

Bone turnover ratio

CT:

Computed tomography

DISH:

Diffuse idiopathic skeletal hyperostosis

PINP:

Propeptide of type I procollagen

References

  1. Kuperus JS, Buckens CF, Šprem J, Oner FC, de Jong PA, Verlaan JJ. The natural course of diffuse idiopathic skeletal hyperostosis in the thoracic spine of adult males. J Rheumatol. 2018;45:1116–23.

    Article  PubMed  Google Scholar 

  2. Fournier DE, Kiser PK, Beach RJ, Dixon SJ, Séguin CA. Dystrophic calcification and heterotopic ossification in fibrocartilaginous tissues of the spine in diffuse idiopathic skeletal hyperostosis (DISH). Bone Res. 2020;8:16. https://doi.org/10.1038/s41413-020-0091-6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Horie S, Sawaji Y, Endo K, Suzuki H, Matsuoka Y, Nishimura H, et al. Factors associated with bone metabolism in patients with cervical ossification of the posterior longitudinal ligament accompanied with diffuse idiopathic skeletal hyperostosis. SICOT J. 2018;4:7. https://doi.org/10.1051/sicotj/2017061.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Yamauchi T, Taketomi E, Matsunaga S, Sakou T. Bone mineral density in patients with ossification of the posterior longitudinal ligament in the cervical spine. J Bone Miner Metab. 1999;17:296–300. https://doi.org/10.1007/s007740050098.

    Article  CAS  PubMed  Google Scholar 

  5. Hirai N, Ikata T, Murase M, Morita T, Katoh S. Bone mineral density of the lumbar spine in patients with ossification of the posterior longitudinal ligament of the cervical spine. J Spinal Disord. 1995;8:337–41.

    Article  CAS  PubMed  Google Scholar 

  6. Kashii M, Matuso Y, Sugiura T, Fujimori T, Nagamoto Y, Makino T, Kaito T, Ebina K, Iwasaki M, Yoshikawa H. Circulating sclerostin and dickkopf-1 levels in ossification of the posterior longitudinal ligament of the spine. J Bone Miner Metab. 2016;34:315–24. https://doi.org/10.1007/s00774-015-0671-5.

    Article  CAS  PubMed  Google Scholar 

  7. Sohn S, Chung CK, Han I, Park SB, Kim H. Increased bone mineral density in cervical or thoracic diffuse idiopathic skeletal hyperostosis (DISH): a case-control study. J Clin Densitom. 2018;21:68–74. https://doi.org/10.1016/j.jocd.2016.09.001.

    Article  PubMed  Google Scholar 

  8. Westerveld LA, Verlaan JJ, Lam MG, Scholten WP, Bleys RL, Dhert WJ, et al. The influence of diffuse idiopathic skeletal hyperostosis on bone mineral density measurements of the spine. Rheumatol (Oxf Engl). 2009;48:1133–6. https://doi.org/10.1093/rheumatology/kep177.

    Article  Google Scholar 

  9. Diederichs G, Engelken F, Marshall LM, Peters K, Black DM, Issever AS, et al. Osteoporotic fractures in Men Research Group. Diffuse idiopathic skeletal hyperostosis (DISH): relation to vertebral fractures and bone density. Osteoporos Int. 2011;22:1789–97. https://doi.org/10.1007/s00198-010-1409-9.

    Article  CAS  PubMed  Google Scholar 

  10. Kuperus JS, Samsour L, Buckens CF, Oner FC, de Jong PA, Verlaan JJ. Bone mineral density changes over time in diffuse idiopathic skeletal hyperostosis of the thoracic spine. Bone. 2018;112:90–6. https://doi.org/10.1016/j.bone.2018.04.005.

    Article  PubMed  Google Scholar 

  11. Furukawa M, Okuyama K, Ninomiya K, Miyamoto T, Yato Y. Assessment of the necessity of osteoporosis treatment for patients with low bone density in diffuse idiopathic skeletal hyperostosis. Spine Surg Relat Res. 2022;6:526–32. https://doi.org/10.22603/ssrr.2021-0149.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Furukawa M, Okuyama K, Kawano Y, Kikuchi K, Miyamoto T, Nakamura M, et al. Femur bone mineral density and pentosidine level distinguish ankylosing spinal disorder patients with and without sacroiliac ankylosis. Spine Surg Relat Res. 2020;4:333–40. https://doi.org/10.22603/ssrr.2020-0001.

    Article  PubMed  PubMed Central  Google Scholar 

  13. Niu CC, Lin SS, Yuan LJ, Chen LH, Yang CY, Chung AN, et al. Correlation of blood bone turnover biomarkers and wnt signaling antagonists with AS, DISH, OPLL, and OYL. BMC Musculoskelet Disord. 2017;18:61. https://doi.org/10.1186/s12891-017-1425-4.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Fassio A, Adami G, Idolazzi L, Giollo A, Viapiana O, Bosco E, et al. Diffuse idiopathic skeletal hyperostosis (DISH) in type 2 diabetes: a new imaging possibility and a new biomarker. Calcif Tissue Int. 2021;108:231–9.

    Article  CAS  PubMed  Google Scholar 

  15. Resnick D, Shaul SR, Robins JM. Diffuse idiopathic skeletal hyperostosis (DISH): Forestier’s disease with extraspinal manifestations. Radiology. 1975;115:513–24. https://doi.org/10.1148/15.3.513.

    Article  CAS  PubMed  Google Scholar 

  16. Furukawa M, Okuyama K, Ninomiya K, Yato Y, Miyamoto T, Nakamura M, et al. Maximum number of bone cross-linked vertebrae: an index for BMD in diffuse idiopathic skeletal hyperostosis. J Bone Miner Metab. 2022;40:308–16. https://doi.org/10.1007/s00774-021-01282-7.

    Article  CAS  PubMed  Google Scholar 

  17. Furukawa M, Okuyama K, Ninomiya K, Yato Y, Miyamoto T, Nakamura M, et al. Association of continuous vertebral bone bridges and bone mineral density with the fracture risk in patients with diffuse idiopathic skeletal hyperostosis. Asian Spine J. 2022;16:75–81.

    Article  PubMed  Google Scholar 

  18. Inose H, Yamada T, Mulati M, Hirai T, Ushio S, Yoshii T, et al. Bone turnover markers as a new predicting factor for nonunion after spinal fusion surgery. Spine. 2018;43:E29–34. https://doi.org/10.1097/BRS.0000000000001995.

    Article  PubMed  Google Scholar 

  19. Wisłowska M, Jakubicz D, Stepień K, Cicha M. Serum concentrations of formation (PINP) and resorption (CTX) bone turnover markers in rheumatoid arthritis. Rheumatol Int. 2009;29:1403–9. https://doi.org/10.1007/s00296-009-0867-x.

    Article  CAS  PubMed  Google Scholar 

  20. Cavalier E, Lukas P, Carlisi A, Gadisseur R, Delanaye P. Aminoterminal propeptide of type I procollagen (PINP) in chronic kidney disease patients: the assay matters. Clin Chim Acta. 2013;425:117–8. https://doi.org/10.1016/j.cca.2013.07.016.

    Article  CAS  PubMed  Google Scholar 

  21. Ivaska KK, Gerdhem P, Akesson K, Garnero P, Obrant KJ. Effect of fracture on bone turnover markers: a longitudinal study comparing marker levels before and after injury in 113 elderly women. J Bone Miner Res. 2007;22:1155–64. https://doi.org/10.1359/jbmr.070505.

    Article  CAS  PubMed  Google Scholar 

  22. Ikegami S, Kamimura M, Nakagawa H, Takahara K, Hashidate H, Uchiyama S, et al. Comparison in bone turnover markers during early healing of femoral neck fracture and trochanteric fracture in elderly patients. Orthop Rev (Pavia). 2009;1:e21. https://doi.org/10.4081/or.2009.e21.

    Article  PubMed  Google Scholar 

  23. Arends S, Spoorenberg A, Efde M, Bos R, Leijsma MK, Bootsma H, et al. Higher bone turnover is related to spinal radiographic damage and low bone mineral density in ankylosing spondylitis patients with active disease: a cross-sectional analysis. PLoS ONE. 2014;9:e99685.

    Article  PubMed  PubMed Central  Google Scholar 

  24. Park MC, Chung SJ, Park YB, Lee SK. Bone and cartilage turnover markers, bone mineral density, and radiographic damage in men with ankylosing spondylitis. Yonsei Med J. 2008;49:288–94. https://doi.org/10.3349/ymj.2008.49.2.288.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Perpétuo IP, Caetano-Lopes J, Vieira-Sousa E, Campanilho-Marques R, Ponte C, Canhão H, et al. Ankylosing spondylitis patients have impaired osteoclast gene expression in circulating osteoclast precursors. Front Med (Lausanne). 2017;4:5. https://doi.org/10.3389/fmed.2017.00005.

    Article  PubMed  Google Scholar 

  26. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum. 1984;27:361–8. https://doi.org/10.1002/art.1780270401.

    Article  PubMed  Google Scholar 

  27. Braun J, Sieper J. Ankylosing spondylitis. Lancet. 2007;369:1379–90. https://doi.org/10.1016/S0140-6736(07)60635-7.

    Article  PubMed  Google Scholar 

  28. Hukuda SI, Minami MI, Saito TE, Mitsui HI, Matsui NO, Komatsubara YO, et al. Spondyloarthropathies in Japan: nationwide questionnaire survey performed by the Japan Ankylosing Spondylitis Society. J Rheumatol. 2001;28:554–9. (Japanese).

    CAS  PubMed  Google Scholar 

  29. Kuo TR, Chen CH. Bone biomarker for the clinical assessment of osteoporosis: recent developments and future perspectives. Biomark Res. 2017;5:18. https://doi.org/10.1186/s40364-017-0097-4.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Yoo JI, Park AJ, Lim YK, Kweon OJ, Choi JH, Do JH, et al. Age-related reference intervals for total collagen-I-N-terminal propeptide in healthy korean population. J Bone Metab. 2018;25:235–41. https://doi.org/10.11005/jbm.2018.25.4.235.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Suda RK, Billings PC, Egan KP, Kim JH, McCarrick-Walmsley R, Glaser DL, Porter DL, Shore EM, Pignolo RJ. Circulating osteogenic precursor cells in heterotopic bone formation. Stem Cells. 2009;27:2209–19. https://doi.org/10.1002/stem.150.

    Article  PubMed  Google Scholar 

  32. TakadaJ, DinavahiR, MiyauchiA, HamayaE, HiramaT, LibanatiC, et al. Relationship between P1NP, a biochemical marker of bone turnover, and bone mineral density in patients transitioned from alendronate to Romosozumab or teriparatide:a post hoc analysis of the structure trial. J Bone Miner Metab. 2020;38:310-5. https://doi.org/10.1007/s00774-019-01057-1.

  33. LiuP, ZhouB, ChenF, DaiZ, KangY. Effect of trabecular microstructure of spinous process on spinal fusion and clinical outcomes after posterior lumbar interbody fusion: bone surface/total volume as independent favorable indicator for fusion success. World Neurosurg. 2020;136:e204-13. https://doi.org/10.1016/j.wneu.2019.12.115.

  34. OkuyamaK, AbeE, SuzukiT, TamuraY, ChibaM, SatoK. Influence of bone mineral density on pedicle screw fixation: a study of pedicle screw fixation augmenting posterior lumbar interbody fusion in elderly patients. Spine J. 2001;1:402-7. https://doi.org/10.1016/s1529-9430(01)00078-x.

  35. WatersRV, GamradtSC, AsnisP, VickeryBH, AvnurZ, HillE, et al. Systemic corticosteroids inhibit bone healing in a rabbit ulnar osteotomy model. Acta Orthop Scand. 2000;71:316 – 21. https://doi.org/10.1080/000164700317411951.

  36. PearsonRG, ClementRG, EdwardsKL, ScammellBE. Do smokers have greater risk of delayed and non-union after fracture, osteotomy and arthrodesis? A systematic review with meta-analysis. BMJ Open. 2016;6:e010303.

  37. ZuraR, Braid-ForbesMJ, JerayK, MehtaS, EinhornTA, WatsonJT, et al. Bone fracture nonunion rate decreases with increasing age: a prospective inception cohort study. Bone. 2017;95:26–32. https://doi.org/10.1016/j.bone.2016.11.006.

  38. OkudaS, OdaT, MiyauchiA, HakuT, YamamotoT, IwasakiM. Surgical outcomes of posterior lumbar interbody fusion in elderly patients. J Bone Joint Surg Am. 2006;88:2714-20. https://doi.org/10.2106/JBJS.F.00186. https://doi.org/10.1136/bmjopen-2015-010303.

  39. UshirozakoH, HasegawaT, EbataS, ObaH, OhbaT, MukaiyamaK, et al. Teriparatide administration and preoperative anterior slippage of the cranial vertebra next to fusion segment < 2 mm promote osseous union after posterior lumbar interbody fusion. Spine. 2019;44:E288-97. https://doi.org/10.1097/BRS.0000000000002833.

  40. KangT, ParkSY, HongSH, LeeJH, LeeSH, ParkJH. Bone union after spinal fusion surgery using local bone in long-term bisphosphonate users: a prospective comparative study. Arch Osteoporos. 2019;14:74. https://doi.org/10.1007/s11657-019-0628-8.

  41. ParkHW, LeeJK, MoonSJ, SeoSK, LeeJH, KimSH. The efficacy of the synthetic interbody cage and Grafton for anterior cervical fusion. Spine. 2009;34:E591-5. https://doi.org/10.1097/BRS.0b013e3181ab8b9a.

  42. KangJ, AnH, HilibrandA, YoonST, KavanaghE, BodenS. Grafton and local bone have comparable outcomes to iliac crest bone in instrumented single-level lumbar fusions. Spine. 2012;37:1083-91. https://doi.org/10.1097/BRS.0b013e31823ed817.

  43. GittensRA, McLachlanT, Olivares-NavarreteR, CaiY, BernerS, TannenbaumR, et al. The effects of combined micron-/submicron-scale surface roughness and nanoscale features on cell proliferation and differentiation. Biomaterials. 2011;32:3395 – 403. https://doi.org/10.1016/j.biomaterials.2011.01.029.

Download references

Acknowledgements

Not applicable.

Funding

None.

Author information

Authors and Affiliations

  1. Department of Orthopedic Surgery, Murayama Medical Center, Tokyo, Japan

    Mitsuru Furukawa

  2. Department of Orthopedic Surgery, Shizuoka City Shimizu Hospital, Shizuoka, Japan

    Reo Shibata & Kunimasa Okuyama

Authors
  1. Mitsuru Furukawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Reo Shibata
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Kunimasa Okuyama
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

MF focused on data collection, data analysis, and writing. RS focused on data collection and data analysis. KO focused on data analysis and writing.

Corresponding author

Correspondence to Mitsuru Furukawa.

Ethics declarations

Ethics approval and consent to participate

All procedures were conducted as per the tenets of the Declaration of Helsinki. The Institutional Review Board of Shizuoka City Shimizu Hospital approved this study (approval no.: 44). Informed consent for participation was obtained from all study participants.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Furukawa, M., Shibata, R. & Okuyama, K. Number of contiguous vertebral cross-links in the spine indicates bone formation: a cross-sectional study. BMC Musculoskelet Disord 24, 736 (2023). https://doi.org/10.1186/s12891-023-06833-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12891-023-06833-9

Keywords

BMC Musculoskeletal Disorders

ISSN: 1471-2474

Contact us